Incisional Negative Pressure Wound Therapy Use to Reduced Surgical Site Complications in Lung Transplant Patients

2019 ◽  
Vol 38 (4) ◽  
pp. S415
Author(s):  
R. Anderson ◽  
M. Weder ◽  
S. Kilbourne
2021 ◽  
Vol 32 ◽  
pp. S144
Author(s):  
E. D’Andrea ◽  
F. Migliozzi ◽  
O. Runti ◽  
L. Di Marco ◽  
C. Bignù ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-6
Author(s):  
Susanna Lam ◽  
Ngee-Soon Lau ◽  
Jerome Martin Laurence ◽  
Deborah Jean Verran

Surgical site infections (SSI) of the abdominal wall in renal transplant recipients can on occasion require management with negative pressure wound therapy (NPWT). This is often successful, with a low risk of further complications. However, we describe three cases in which persistent or recurrent surgical site sepsis occurred, whilst NPWT was being deployed in adults with either wound dehiscence or initial SSI. This type of complication in the setting of NPWT has not been previously described in renal transplant recipients. Our case series demonstrates that in immunosuppressed transplant recipients, there may be ineffective microbial or bacterial bioburden clearance associated with the NPWT, which can lead to further infections. Hence recognition for infections in renal transplant patients undergoing treatment with NPWT is vital; furthermore, aggressive management of sepsis control with early debridement, antimicrobial use, and reassessment of the use of wound dressing is necessary to reduce the morbidity associated with surgical site infections and NPWT.


2020 ◽  
Vol 3 (1) ◽  
pp. 30-38
Author(s):  
Nicholas Savage ◽  
Mohit Jain ◽  
Robert Champion ◽  
Broughton Snell

Introduction: Incisional negative pressure wound therapy (iNPWT) has been applied to bilateral breast reduction patients and shown a reduction in surgical complications. However, its effects on opioid use and hospitalisation length in this patient group has not been investigated.Methods: In this single surgeon retrospective cohort study, 52 patients who underwent bilateral breast reduction were analysed, with 23 patients in the iNPWT cohort and 29 in the standard-of-care (SOC) wound dressing cohort. Hospitalisation length, postoperative opioid use and surgical site complications were compared between cohorts. Mean (range) follow-up time was 369.15 (77-1329) days.Results: Hospitalisation length in days was significantly less in the iNPWT cohort (1.35) than the SOC cohort (2.03). Total ward opioid use was significantly reduced in the iNPWT cohort (45.50mg) compared to the SOC cohort (62.50mg). Discharge opioid prescription was significantly reduced in the iNPWT cohort (125.50mg) compared to the SOC cohort (230.00mg). The number of surgical site complications was significantly different between the groups (p=0.014).Discussion: This study suggests the use of iNPWT in bilateral breast reduction provides significant benefit through the reduction of hospitalisation, complications and opioid use. Conclusion: This is the first study to provide evidence for iNPWT in bilateral breast reduction in reducing postoperative opioid use and hospitalisation. It supports current literature showing a reduction in surgical site complications using iNPWT in bilateral breast reduction.


Sign in / Sign up

Export Citation Format

Share Document